3.94
price up icon1.03%   0.04
pre-market  Vorhandelsmarkt:  3.94  
loading
Schlusskurs vom Vortag:
$3.90
Offen:
$3.88
24-Stunden-Volumen:
923.25K
Relative Volume:
1.02
Marktkapitalisierung:
$501.26M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-43.78
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
-5.06%
1M Leistung:
-0.76%
6M Leistung:
+2.07%
1J Leistung:
-22.90%
1-Tages-Spanne:
Value
$3.795
$3.94
1-Wochen-Bereich:
Value
$3.705
$4.22
52-Wochen-Spanne:
Value
$2.37
$7.63

Cytek Biosciences Inc Stock (CTKB) Company Profile

Name
Firmenname
Cytek Biosciences Inc
Name
Telefon
(877) 922-9835
Name
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Name
Mitarbeiter
688
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
CTKB's Discussions on Twitter

Vergleichen Sie CTKB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
CTKB
Cytek Biosciences Inc
3.94 496.17M 193.01M -12.15M 454.00K -0.09
Medical Devices icon
ABT
Abbott Laboratories
123.84 214.96B 43.84B 13.90B 6.92B 7.9725
Medical Devices icon
BSX
Boston Scientific Corp
98.59 149.24B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
358.16 136.23B 24.38B 2.94B 4.07B 7.6159
Medical Devices icon
MDT
Medtronic Plc
90.20 116.33B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
83.07 48.41B 5.88B 1.34B 577.90M 2.3455

Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-09 Herabstufung TD Cowen Buy → Hold
2025-01-31 Herabstufung Goldman Buy → Sell
2023-12-14 Eingeleitet Stephens Overweight
2023-07-19 Eingeleitet Raymond James Mkt Perform
2022-01-06 Fortgesetzt Piper Sandler Overweight

Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten

pulisher
01:20 AM

Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumEarnings Risk Report & Free Real-Time Volume Trigger Notifications - newser.com

01:20 AM
pulisher
Nov 03, 2025

How Cytek Biosciences Inc. stock reacts to bond yields2025 EndofYear Setup & Fast Entry High Yield Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Multi factor analysis applied to Cytek Biosciences Inc.Index Update & Risk Controlled Daily Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How supply chain issues affect Cytek Biosciences Inc. stockRisk Management & Free Community Consensus Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Cytek Biosciences Inc. (8EQ) stock overpriced at current multiplesJuly 2025 Summary & Proven Capital Preservation Methods - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Cytek Biosciences Inc. stock supported by innovation pipelineMarket Risk Analysis & Safe Entry Zone Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Cytek Biosciences Inc. stock maintain growth trajectoryQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Does Cytek Biosciences Inc. stock trade at a discount to peersWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can a trend reversal in Cytek Biosciences Inc. lead to recovery - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Comparing Cytek Biosciences Inc. in custom built stock radarsBull Run & Weekly High Potential Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Smart tools for monitoring Cytek Biosciences Inc.’s price actionGold Moves & Short-Term Trading Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Applying Elliott Wave Theory to Cytek Biosciences Inc.July 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Cytek Biosciences Inc. (8EQ) stock beat growth indexesJuly 2025 Recap & Technical Buy Zone Confirmations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Understanding Cytek Biosciences Inc.’s price movementJuly 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

How strong dollar benefits Cytek Biosciences Inc. (8EQ) stockQuarterly Portfolio Review & Proven Capital Preservation Methods - newser.com

Nov 01, 2025

Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Cytek Biosciences Inc-Aktie (CTKB) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
McCombe William D.
Chief Financial Officer
Jun 02 '25
Buy
2.78
35,000
97,300
55,746
$318.77
price up icon 1.84%
medical_devices STE
$237.32
price up icon 0.69%
$60.43
price up icon 3.80%
medical_devices PHG
$27.21
price down icon 0.40%
$74.47
price down icon 0.64%
medical_devices EW
$83.07
price up icon 0.75%
Kapitalisierung:     |  Volumen (24h):